Literature DB >> 3929531

Incidence of Hb Barts and alpha-thalassaemia genotypes in a South African population.

J Rousseau, C G Mathew, J S Rees, E du Toit, M C Botha, E H Harley.   

Abstract

The cord blood of 1,207 randomly selected neonates from the Cape Coloured population of South Africa was analysed for the presence of Hb Barts. 40 individuals (3.3%) had detectable Hb Barts levels with values ranging from 1.1 to 7.3%. Restriction enzyme analysis of DNA from subjects with Hb Barts showed that 85% of the cases studied had the genotypes -alpha 3.7/alpha alpha or -alpha 3.7/-alpha 3.7. The observed frequency of the -alpha/alpha alpha genotype was much lower than the expected frequency which suggests that this genotype is often not associated with detectable levels of Hb Barts. Mapping of the sigma-globin locus in three subjects with HbH disease revealed the presence of the--SEA/alpha-thalassaemia determinant in this population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929531     DOI: 10.1159/000206310

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Different hematologic phenotypes are associated with the leftward (-alpha 4.2) and rightward (-alpha 3.7) alpha+-thalassemia deletions.

Authors:  D K Bowden; A V Hill; D R Higgs; S J Oppenheimer; D J Weatherall; J B Clegg
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

2.  Inherited haemoglobin variants in a South African population.

Authors:  A R Bird; P Ellis; K Wood; C Mathew; C Karabus
Journal:  J Med Genet       Date:  1987-04       Impact factor: 6.318

3.  The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.

Authors:  Daniel R Jacobson; Alice A Alexander; Clement Tagoe; W T Garvey; Scott M Williams; Sara Tishkoff; David Modiano; Sodiomon B Sirima; Issa Kalidi; Amadou Toure; Joel N Buxbaum
Journal:  Mol Genet Genomic Med       Date:  2016-07-14       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.